Vascular endothelial growth factor production in polymyalgia rheumatica

Arthritis and Rheumatism

Volumn 43, Issue 11, 2000, Pages 2472-2480

  Meliconi, Riccardo ^a   Pulsatelli, Lia ^b   Dolzani, Paolo ^b   Boiardi, Luigi ^c   Macchioni, Pierluigi ^c   Salvarani, Carlo ^c   Silvestri, Tania ^b   Frizziero, Luigi ^d   Facchini, Andrea ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c S MARIA NUOVA HOSPITAL   (Italy)

^d MAGGIORE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; PATHOGENESIS; PRIORITY JOURNAL; RHEUMATIC POLYMYALGIA; SYNOVITIS; TREATMENT OUTCOME;

ENDOTHELIAL GROWTH FACTORS; IMMUNOHISTOCHEMISTRY; INTEGRINS; LEUKOCYTES, MONONUCLEAR; LYMPHOKINES; POLYMYALGIA RHEUMATICA; PROTEIN ISOFORMS; SYNOVIAL MEMBRANE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033764658     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200011)43:11<2472::AID-ANR14>3.0.CO;2-B     Document Type: Article

References (60)

1. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991
2. Polymyalgia rheumatica
3. Distal musculoskeletal manifestations in polymyalgia rheumatica: A prospective followup study
4. Musculoskeletal manifestations in a population-based cohort of patients with giant cell arteritis
5. Long-term follow-up of polymyalgia rheumatica: Evidence for synovitis
6. Joint imaging in polymyalgia rheumatica
7. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica: Quantitative analysis and influence of corticosteroid treatment
8. Synovial expression of cell adhesion molecules in polymyalgia rheumatica
9. Proximal bursitis in active polymyalgia rheumatica
10. Giant cell arteritis and polymyalgia rheumatica
11. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis
12. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis: Evidence for two components of the disease
13. HLA-DRB1 alleles in polymyalgia rheumatica, giant cell arteritis, and rheumatoid arthritis
14. Angiogenesis: A critical process in the pathogenesis of RA - A role for VEGF?
15. Angioneogenesis as a possible elusive triggering factor in rheumatoid arthritis
16. Formation of new vasa vasorum in vasculitis: Production of angiogenic cytokines by multinucleated giant cells
17. Angiogenesis: Implications for rheumatoid arthritis
18. Vascular endothelial growth factor (VEGF) and its receptors
19. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration
20. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells
21. Simultaneous in vivo quantitation of vascular endothelial growth factor mRNA splice variants
22. Role of vascular endothelial growth factor in the regulation of angiogenesis
23. Vascular endothelial growth factor: A cytokine modulating endothelial function in rheumatoid arthritis
24. Role of vascular endothelial growth factor in angiogenesis of rheumatoid arthritis
25. Serum levels of vascular endothelial growth factor (VEGF) are markedly elevated in patients with Wegener's granulomatosis
26. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor α and interleukin-1 in rheumatoid arthritis
27. Vascular endothelial growth factor in patients with rheumatoid arthritis
28. Peripheral blood mononuclear cells from patients with rheumatoid arthritis spontaneously secrete vascular endothelial growth factor (VEGF): Specific up-regulation by tumour necrosis factor-alpha (TNF-α) in synovial fluid
29. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
30. Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1β
31. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
32. Arthroscopy of the shoulder joint: A review of 23 cases
33. Elevated serum vascular endothelial growth factor in children and young adults with Crohn's disease
34. Vascular endothelial growth factor in acute Kawasaki disease
35. Serum vascular endothelial growth factor is often elevated in disseminated cancer
36. Platelet: Transporter of vascular endothelial growth factor
37. Vascular endothelial growth factor platelet counts, and prognosis in renal cancer
38. Space flight and growth factors
39. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease
40. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
41. Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation
42. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets
43. Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets
44. Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients
45. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis
46. Increased production of vascular endothelial growth factor by peripheral blood mononuclear cells in patients with inflammatory bowel disease
47. 165 labeling of peripheral CD14+ monocytes
48. Plasminogen activator inhibitor and von Willebrand factor in polymyalgia rheumatica
49. Long term follow up of von Willebrand factor and plasminogen activator inhibitor-1 in patients with polymyalgia rheumatica
50. Hypoxia augments cytokine (transforming growth factor-beta [TGF-β] and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts
51. Interleukin 6 induces the expression of vascular endothelial growth factor
52. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis
53. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis
54. Cytokines and adhesion molecules in patients with polymyalgia rheumatica
55. Treatment of giant cell arteritis: Interleukin-6 as a biologic marker of disease activity
56. Inhibitory effects of anti-rheumatic drugs on vascular endothelial growth factor in cultured rheumatoid synovial cells
57. Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: Possible pathophysiological significance of VEGF in progression of atherosclerosis
58. Immunohistochemical expression of vascular endothelial growth factor/vascular permeability factor in atherosclerotic intimas of human coronary arteries
59. Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist
60. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma